CONFERENCE COVERAGE SERIES Chicago: 2nd Annual Symposium Explores ApoE ApoE, ApoE Receptors & Neurodegeneration, 2011
PAPER Daley GQ, Scadden DT
Cell. 2008 Feb 22;132(4):544-8. PubMed: 18295571
PAPER Hockemeyer D, Wang H, Kiani S, Lai CS, Gao Q, Cassady JP, Cost GJ, Zhang L, Santiago Y, Miller JC, Zeitler B, Cherone JM, Meng X, Hinkley SJ, Rebar EJ, Gregory PD, Urnov FD, Jaenisch R
Nat Biotechnol. 2011 Aug;29(8):731-4. PubMed: 21738127
PAPER Bock C, Kiskinis E, Verstappen G, Gu H, Boulting G, Smith ZD, Ziller M, Croft GF, Amoroso MW, Oakley DH, Gnirke A, Eggan K, Meissner A
Cell. 2011 Feb 4;144(3):439-52. PubMed: 21295703
CONFERENCE COVERAGE 2011-07-26 Conference Coverage Download a PDF of this report. Apolipoprotein E (ApoE) gene alleles are the strongest genetic modulators of late-onset Alzheimer's disease (AD) risk. Some 60 percent of AD individuals carry at least one copy of the ApoE4 variant.
RESEARCH NEWS 2011-07-26 Research News Now that they can make induced pluripotent stem cells from anyone, scientists are near-giddy with excitement over the potential to model diseases in cell lines, as well as someday correct genetic mutations in people (see ARF news series). Bu
RESEARCH NEWS 2011-07-26 Research News Sifting through the sequence of all the coding bits of the genome, two independent groups have identified a new mutation that causes Parkinson’s disease. The mutation sits in the gene for vacuolar protein sorting 35 (VPS35), altering its par
WEBINAR 2011-07-26 Alzforum has been pleased to partner with the journal Science Translational Medicine in hosting a Webinar discussion of a new Alzheimer’s disease research study published 29 June 2011. The journal generously granted free access to Castellano et al. for Al